110 related articles for article (PubMed ID: 25183399)
1. Comparative screening and validation as a novel tool to identify STAT-specific inhibitors.
Szeląg M; Czerwoniec A; Wesoly J; Bluyssen HA
Eur J Pharmacol; 2014 Oct; 740():417-20. PubMed ID: 25183399
[TBL] [Abstract][Full Text] [Related]
2. Identification of STAT1 and STAT3 specific inhibitors using comparative virtual screening and docking validation.
Szelag M; Czerwoniec A; Wesoly J; Bluyssen HA
PLoS One; 2015; 10(2):e0116688. PubMed ID: 25710482
[TBL] [Abstract][Full Text] [Related]
3. Targeted inhibition of STATs and IRFs as a potential treatment strategy in cardiovascular disease.
Szelag M; Piaszyk-Borychowska A; Plens-Galaska M; Wesoly J; Bluyssen HA
Oncotarget; 2016 Jul; 7(30):48788-48812. PubMed ID: 27166190
[TBL] [Abstract][Full Text] [Related]
4. In silico simulations of STAT1 and STAT3 inhibitors predict SH2 domain cross-binding specificity.
Szelag M; Sikorski K; Czerwoniec A; Szatkowska K; Wesoly J; Bluyssen HA
Eur J Pharmacol; 2013 Nov; 720(1-3):38-48. PubMed ID: 24211327
[TBL] [Abstract][Full Text] [Related]
5. Genome-Wide Inhibition of Pro-atherogenic Gene Expression by Multi-STAT Targeting Compounds as a Novel Treatment Strategy of CVDs.
Plens-Galaska M; Szelag M; Collado A; Marques P; Vallejo S; Ramos-González M; Wesoly J; Sanz MJ; Peiró C; Bluyssen HAR
Front Immunol; 2018; 9():2141. PubMed ID: 30283459
[TBL] [Abstract][Full Text] [Related]
6. Advances in peptidic and peptidomimetic-based approaches to inhibit STAT signaling in human diseases.
Szelag M; Wesoly J; Bluyssen HA
Curr Protein Pept Sci; 2016; 17(2):135-46. PubMed ID: 26521960
[TBL] [Abstract][Full Text] [Related]
7. Exploring dual inhibitors for STAT1 and STAT5 receptors utilizing virtual screening and dynamics simulation validation.
Raj U; Kumar H; Gupta S; Varadwaj PK
J Biomol Struct Dyn; 2016 Oct; 34(10):2115-29. PubMed ID: 26471877
[TBL] [Abstract][Full Text] [Related]
8. High-throughput thermofluor-based assays for inhibitor screening of STAT SH2 domains.
de Araujo ED; Manaswiyoungkul P; Israelian J; Park J; Yuen K; Farhangi S; Berger-Becvar A; Abu-Jazar L; Gunning PT
J Pharm Biomed Anal; 2017 Sep; 143():159-167. PubMed ID: 28600954
[TBL] [Abstract][Full Text] [Related]
9. Dd-STATb, a Dictyostelium STAT protein with a highly aberrant SH2 domain, functions as a regulator of gene expression during growth and early development.
Zhukovskaya NV; Fukuzawa M; Tsujioka M; Jermyn KA; Kawata T; Abe T; Zvelebil M; Williams JG
Development; 2004 Jan; 131(2):447-58. PubMed ID: 14701681
[TBL] [Abstract][Full Text] [Related]
10. The role of STATs in transcriptional control and their impact on cellular function.
Bromberg J; Darnell JE
Oncogene; 2000 May; 19(21):2468-73. PubMed ID: 10851045
[TBL] [Abstract][Full Text] [Related]
11. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention.
Buettner R; Mora LB; Jove R
Clin Cancer Res; 2002 Apr; 8(4):945-54. PubMed ID: 11948098
[TBL] [Abstract][Full Text] [Related]
12. Roles of unphosphorylated STATs in signaling.
Yang J; Stark GR
Cell Res; 2008 Apr; 18(4):443-51. PubMed ID: 18364677
[TBL] [Abstract][Full Text] [Related]
13. JAK/STAT pathway plays a critical role in the proinflammatory gene expression and apoptosis of RAW264.7 cells induced by trichothecenes as DON and T-2 toxin.
Wang X; Liu Q; Ihsan A; Huang L; Dai M; Hao H; Cheng G; Liu Z; Wang Y; Yuan Z
Toxicol Sci; 2012 Jun; 127(2):412-24. PubMed ID: 22454431
[TBL] [Abstract][Full Text] [Related]
14. Detection of activated STAT proteins.
Parisien JP; Horvath CM
Methods Mol Biol; 2013; 967():135-45. PubMed ID: 23296726
[TBL] [Abstract][Full Text] [Related]
15. STAT-mediated EGFR signaling in cancer.
Quesnelle KM; Boehm AL; Grandis JR
J Cell Biochem; 2007 Oct; 102(2):311-9. PubMed ID: 17661350
[TBL] [Abstract][Full Text] [Related]
16. JAK/STAT signal transduction: regulators and implication in hematological malignancies.
Valentino L; Pierre J
Biochem Pharmacol; 2006 Mar; 71(6):713-21. PubMed ID: 16426581
[TBL] [Abstract][Full Text] [Related]
17. STAT-3 inhibitors: state of the art and new horizons for cancer treatment.
Lavecchia A; Di Giovanni C; Novellino E
Curr Med Chem; 2011; 18(16):2359-75. PubMed ID: 21568920
[TBL] [Abstract][Full Text] [Related]
18. Sophoraflavanone G induces apoptosis of human cancer cells by targeting upstream signals of STATs.
Kim BH; Won C; Lee YH; Choi JS; Noh KH; Han S; Lee H; Lee CS; Lee DS; Ye SK; Kim MH
Biochem Pharmacol; 2013 Oct; 86(7):950-9. PubMed ID: 23962443
[TBL] [Abstract][Full Text] [Related]
19. Identification of non-phosphate-containing small molecular weight inhibitors of the tyrosine kinase p56 Lck SH2 domain via in silico screening against the pY + 3 binding site.
Huang N; Nagarsekar A; Xia G; Hayashi J; MacKerell AD
J Med Chem; 2004 Jul; 47(14):3502-11. PubMed ID: 15214778
[TBL] [Abstract][Full Text] [Related]
20. Signal transducers and activators of transcription as targets for small organic molecules.
Berg T
Chembiochem; 2008 Sep; 9(13):2039-44. PubMed ID: 18677740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
